Insights

Outsourcing Your Parenteral Manufacturing – Choosing the Optimal CDMO

icons/content-types/article article

Drug Product

Track records, product handling limitations, and cost are all factors to consider when outsourcing parenteral manufacturing. Choosing the right CDMO partner is not an easy task, but Curia has resources to make the decision easier. To learn more, Pharmaceutical Technology sat down with Dr. Ronald Aungst [Vice President, Portfolio and Sourcing for Drug Product, Curia] to discuss what CDMOs have to offer and how these partnerships can improve tech transfers and drug product development.

Download the Article

Ready to move from idea to impact?

Whether you have a question for our team or an opportunity you’re eager to pursue, one of our experts can help you get started.

Contact Us
More from Curia

icons/content-types/article article

Trends and Challenges in the Pharmaceutical Industry

Significant changes have taken place in the life sciences industry over the past few years. Since the Covid-19 pandemic, the U.S. government has urged biotech and pharmaceutical companies to increase domestic production in order to secure the drug su...

icons/content-types/white paper white paper

Continuous Flow - An Emerging Alternative

With the growing complexity of drug molecules and the need to involve newer and harsher reaction conditions that were once thought of as unfriendly in process chemistry, continuous flow chemistry and processing offer a proven alternative pathway.